Birmingham Biotech, an innovator in diagnostic tests, protective nasal sprays and mobile medical facilities, launches NoriZite Nasal Spray, an easy-to-use nasal device designed to block and trap inhaled virus particles, into the UK market.
Luigi Boltri, PH.D., senior director, Pharmaceutical Sciences, Adare Pharma Solutions, addresses the challenges of paediatric formulations, and how specialised technology platforms can provide ease of application and improve patient outcomes.
LLS Health's experts, Joey Glassco, MBA, Injectable Drug Delivery, and Nick DiFranco, MEM, global market segment manager, share the API solubility puzzle that the pharma industry faces and how to solve it.
Dr. Julia Rashba-Step, VP of R&D and Alliance Management at Phosphorex, explains how its using microfluidics to help its clients accelerate their nanoparticle fabrication and forward the development of new nanomedicines.
Michael Earl, director, Pharmaceutical Services at Owen Mumford, explains how Owen Mumford’s Covid-compliant study design and careful planning allowed them to finalise their product design and present this innovative product to the market.
Mark Tunkel, global category director, Services at Nemera, explores the factors that should be considered when developing a device strategy in the current technology landscape, and how a holistic approach can lead to better decisions.
Portescap’s Jigar Fulia and Kanti Vala consider the selection criteria for biologics system motion solutions in delivery devices, and how this can help meet patient needs.
Rebekah Jordan caught up with Cindy Reiss-Clark, chief commercial officer of West, at the recent Pharmapack show, to talk about its latest innovations and progress through the pandemic.
Terumo Pharmaceutical Solutions (TPS), a manufacturer of injection, primary container, and infusion therapy devices, has launched a pre-fillable polymer syringe for low dose applications such as ophthalmic drugs.
Finola Austin - human factors engineering manager, Owen Mumford Pharmaceutical Services outlines a sampling strategy which can be used as a framework for manufacturers to carry out user evaluation without identification of a specified user group.
Tim Gardner, director of Manufacturing & NPI at Vectura explores the considerations to make when manufacturing formulations for dry powder inhaled products.
Pedro Lichtinger, CEO and chairman of biotech Starton Therapeutics, speaks to EPM about the company’s mission to improve cancer care using transdermal technology.
